
INHERITANCE OF A CHROMOSOME 3 AND 21
TRANSLOCATION IN THE FETUSES, WITH ONE ALSO
HAVING TRISOMY 21, IN THREE PREGNANCIES
IN ONE FAMILY Pazarbasi A1,*, Demirhan O1, Alptekin D1, Ozgunen FT2, Ozpak L1,
Yilmaz MB1, Nazlican E3, Tanriverdi N1, Luleyap U1, Gümürdülü D4 *Corresponding Author: Associate Professor Ayfer Pazarbasi (Ph.D.), Çukurova University, Faculty of Medicine,
Department of Medical Biology and Genetics, 01330 Adana, Turkey; Tel.: +90-322-338-6060/3498; Fax:
+90-322-338-6572; E-mail: payfer@cu.edu.tr page: 91
|
MATERIALS AND METHODS
Subjects. A 30-year-old woman with a history
of two previous pregnancies was referred by the Department
of Obstetrics and Gynecology, Çukurova
University, Adana, Turkey, to our genetics laboratory for prenatal diagnosis due to having a terminated
pregnancy because of a fetus with Down Syndrome
and a risk of positive triple test screening at 16 weeks
of gestation. The biopsy of the terminated fetus was
performed by the pathology department of our faculty
for confirmation. The woman and her 35-year-old
husband were healthy and phenotypically normal.
Both parents were subjected to chromosomal analysis,
based on standard blood lymphocyte culture and
G-banding techniques. Twenty metaphases were microscopically
analyzed for the parents. They were
not consanguineous and the mother had become
pregnant a total of three times, as can be seen in
the pedigree of the family (Figure 1). Of these three
pregnancies, only one resulted in the birth of a phenotypically
and karyotypically normal male baby.
Cytogenetic Analyses and Findings. Karyotypes
of the fetuses of the second generation of the
family’s pedigree were performed on fetal cells
that were obtained from the amniotic fluid sample
by using a long-term cell culture. After adequate
growth, cultures were harvested after an average 8
to 10 days. Karyotyping was routinely performed
by G-banding using the trypsin-Giemsa staining
technique. At least 20 metaphases were analyzed.
Chromosome analysis confirmed that all cells of the
mother had a translocation between chromosomes 3
and 21; her karyotype was 46,XX,t(3;21)(q21;q22)
(Figure 2). The father’s karyotype was normal. In
the mother’s first pregnancy, the fetus was a carrier
of the translocation between chromosomes 3 and 21 with trisomy 21; the karyotype of these fetus was
47,XX,+21,t(3;21)(q21;q22) (Figure 3). The family
decided to terminate the pregnancy in the second
trimester. The diagnosis of Down Syndrome was
verified at the clinical examination of the terminated
fetus. Bilateral telecanthus (+), nose origin flatness
(+), back of neck was short and abundant nuchal
skin with cystic hygroma residues (Figure 4A, 4B
and 4C). Brachydactylia was also seen on the right
hand’s third finger (+) and clinodactyly of both right
and left hands’ fifth finger (+) (Figure 4A, 4B and
4C). Simian line was observed on both right and
left hands (Figure 4A, 4B and 4C). The fetus was
phenotypic-ally female. Of these pregnancies, only
the second resulted with the birth of phenotypically
and karyotypically normal male baby. In the third pregnancy, the fetus was a carrier of the translocation
between chromosomes 3 and 21; the karyotype
of this fetus was 46,XX,t(3;21)(q21;q22) (Figure 5).
This pregnancy was also terminated in the second
trimester at the family decision.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|